Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

With New Center, DCI Tackles Brain Metastasis Head-On

During the summer of 2016 Dave and Lisa VanTress retired from their jobs in Syracuse, New York, and headed south to the sunny shores of South Carolina, where they could be close to family and indulge their passion for fishing. They bought a townhouse in Little River, a five-minute drive to the...

Oncology Nurses Serve Up Meals Warming Body And Soul

Whether on the job, at home or beyond, compassion seems to be an essential characteristic that comes naturally for most nurses. Nowhere is this illustrated better than through the team of nurses manning Clinic 3-2 at Duke Cancer Center. When thoracic oncology medical assistant Suzanne Matkins, CMA...

Researchers Identify New Way to Unmask Melanoma Cells to the Immune System

Melanomas have an especially lethal ability to turn off the body’s immune system, which enables these deadly skin cancers to grow and spread. And while new therapies have been effective in releasing the immune system’s restraints to unleash the body’s own cancer-fighting powers, they only work in...

Salama Receives NCI Clinical Investigator Team Leadership Award

April Salama, MD, interim director of Duke Cancer Institute’s Melanoma Program, has been named a recipient of one of ten 2017 National Cancer Institute Cancer Clinical Investigator Team Leadership Awards. “Dr. Salama has advanced the melanoma clinical research program at Duke Cancer Institute,...

Hanks Team Awarded $500,000 to Study Immunotherapy Resistance

A team of Duke Cancer Institute researchers led by Brent Hanks, MD, PhD, has been awarded a two-year, $500,000 grant from Merck & Co., Inc., to investigate clinical biomarkers of immunotherapy resistance in melanoma. Hanks is the principle investigator of the group that includes Bala...

Immunotherapy Target Suppresses Pain to Mask Cancer

Once hailed as a breakthrough in cancer treatment, immunotherapies are now raising concerns as doctors note new side effects like severe allergic reactions, acute-onset diabetes and heart damage. These drugs, which work by unleashing the immune system to fight cancer, are only effective in about a...

Teacher, Melanoma Survivor, Thanks Her DCI “Dragonslayer”

Fourth grade teacher Tricia Gallagher was 43 when she felt something like a scab — smaller than a sunflower seed — on her head. She didn’t think much of it. “I thought it was a tick, because my boys and I hike,” said the energetic mother of two active teenagers. Her doctor in Winston Salem, North...

Blackman Named Admin. Director For GI And Melanoma

Kristen Blackman, MHA, formerly administrative director for clinical operations for Neurosciences and Musculoskeletal Services at Duke University Hospital, was named this fall to serve as administrative director for the DCI’s GI and Melanoma Cancer Programs. “I am delighted that Kristen elected to...